Immunic (IMUX) Change in Cash (2013 - 2026)

Immunic has reported Change in Cash for 14 years, with the latest figure at $171.1 million in Q1 2026.

• Quarterly Change in Cash rose 901.1% year-over-year to $171.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $172.3 million (up 307.6% YoY) and the FY2025 annual result came in at -$20.2 million, down 83.4% from the prior year.
• Change in Cash grew to $171.1 million in Q1 2026 per IMUX's latest filing, from -$19.6 million in the prior quarter.
• Over five years, Change in Cash peaked at $171.1 million in Q1 2026 and troughed at -$23.4 million in Q4 2024.
• A 5-year average of $5.9 million and a median of -$15.3 million in 2022 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2023 and 2026: Change in Cash tumbled 258.06% in 2023, then surged 901.1% in 2026.
• Over 5 years, Change in Cash stood at $34.0 million in 2022, then sank by 138.31% to -$13.0 million in 2023, then plunged by 79.82% to -$23.4 million in 2024, then rose by 16.04% to -$19.6 million in 2025, then soared by 971.02% to $171.1 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered $171.1 million, -$19.6 million, and -$20.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.